Capital Research Global Investors Albemarle Corp Transaction History
Capital Research Global Investors
- $463 Billion
- Q3 2024
A detailed history of Capital Research Global Investors transactions in Albemarle Corp stock. As of the latest transaction made, Capital Research Global Investors holds 2,943,533 shares of ALB stock, worth $322 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,943,533
Previous 7,168,766
58.94%
Holding current value
$322 Million
Previous $685 Million
59.29%
% of portfolio
0.06%
Previous 0.15%
Shares
16 transactions
Others Institutions Holding ALB
# of Institutions
928Shares Held
104MCall Options Held
8.36MPut Options Held
14.3M-
Vanguard Group Inc Valley Forge, PA14.2MShares$1.56 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY9.96MShares$1.09 Billion0.02% of portfolio
-
State Street Corp Boston, MA6.56MShares$718 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA6.4MShares$701 Million0.1% of portfolio
-
Primecap Management CO Pasadena, CA3.83MShares$420 Million0.27% of portfolio
About ALBEMARLE CORP
- Ticker ALB
- Exchange NYSE
- Sector Basic Materials
- Industry Specialty Chemicals
- Shares Outstandng 117,129,000
- Market Cap $12.8B
- Description
- Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...